[ADPT] Adeptus Health Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Hospital/Nursing Management

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 7.81 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart ADPT

Refresh chart

Description: Adeptus Health Inc. focuses on operating a network of independent freestanding emergency rooms in the United States. It operates 32 facilities located in the Houston, Dallas/Fort Worth, San Antonio, and Austin of Texas, as well as Colorado Springs and Denver of Colorado. The company was founded in 2002 and is based in Lewisville, Texas.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS5.95 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 84.12% Sales Growth - Q/Q16.24% P/E0.24
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-0.91% ROE-5.61% ROI-1.31%
Current Ratio2.59 Quick Ratio2.46 Long Term Debt/Equity2.35 Debt Ratio0.72
Gross Margin Operating Margin-0.37% Net Profit Margin-1.09% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities23.26 M Cash From Investing Activities570 K Cash From Operating Activities-11.96 M Gross Profit31.88 M
Net Profit590 K Operating Profit5.35 M Total Assets302.29 M Total Current Assets91.56 M
Total Current Liabilities35.41 M Total Debt134.27 M Total Liabilities253.14 M Total Revenue80.76 M
Technical Data
High 52 week72.35 Low 52 week0.98 Last close1.41 Last change0%
RSI45.42 Average true range0.49 Beta1.12 Volume922.38 K
Simple moving average 20 days-10.39% Simple moving average 50 days-58.29% Simple moving average 200 days-93.46%
Performance Data
Performance Week-37.33% Performance Month-19.89% Performance Quart-82.4% Performance Half-96.28%
Performance Year-97.84% Performance Year-to-date-81.54% Volatility daily19.86% Volatility weekly44.4%
Volatility monthly90.99% Volatility yearly315.2% Relative Volume324.05% Average Volume2.39 M
New High New Low

News

2020-05-19 08:03:12 | 5 Biotech Stocks in Focus as Race for Coronavirus Vaccine Heats Up

2020-05-18 14:47:12 | Moderna COVID-19 vaccine data is ‘baby-step’ in right direction: Expert

2020-05-14 11:51:09 | Coronavirus Vaccine Progress Accelerates

2020-05-13 12:31:14 | Adaptive Biotechnologies Corporation ADPT Q1 2020 Earnings Call Transcript

2020-05-13 07:02:00 | What's Behind Adaptive Biotechnologies' Q1 Earnings Miss

2020-05-13 07:02:00 | What's Behind Adaptive Biotechnologies' Q1 Earnings Miss

2020-05-12 16:03:10 | Adaptive Biotechnologies Reports First Quarter 2020 Financial Results

2020-05-12 08:06:36 | The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings

2020-05-11 10:57:02 | Biotech Stock Q1 Earnings Due on May 12: ADPT, VIR, TPTX

2020-05-11 09:57:01 | Is a Surprise Coming for Adaptive Biotechnologies ADPT This Earnings Season?

2020-05-08 09:09:01 | Is a Beat in Store for Sunoco SUN This Earnings Season?

2020-05-06 14:50:00 | These 23 companies are working on coronavirus treatments or vaccines — here’s where things stand

2020-05-06 12:10:00 | Adaptive Biotechnologies and Microsoft Announce New Study of COVID-19 Immune Response

2020-05-06 12:01:00 | Coronavirus update: U.S. death toll tops 71,000, as Trump backs off plan to wind down pandemic task force

2020-05-06 08:19:00 | Adaptive, Microsoft to conduct study evaluating T-cells in COVID-19 patients

2020-05-06 08:00:10 | Adaptive Biotechnologies to Present at the BofA Securities 2020 Healthcare Conference

2020-05-05 12:00:00 | Adaptive Biotechnologies and Microsoft launch virtual ImmuneRACE study to inform novel COVID-19 diagnostics to address unmet needs in testing

2020-04-30 08:51:12 | Remdesivir Progresses on Coronavirus Trial: Pharma Upbeat

2020-04-30 06:39:00 | Better Buy: Illumina vs. Adaptive Biotechnologies

2020-04-27 16:03:10 | Adaptive Biotechnologies to Report First Quarter Financial Results on May 12, 2020

2020-04-20 08:15:12 | Gilead Increases Enrollment Target, Pharma Rally Continues

2020-04-17 21:13:29 | Adaptive Biotechnologies’ Collaborations Could Be Vital in Fight Against COVID-19

2020-04-17 12:40:22 | 4 Healthcare Stocks to Buy For Coronavirus Innovation

2020-04-15 16:47:43 | Andreas Halvorsen Checks Into Zentalis Pharmaceuticals

2020-04-15 08:26:12 | Pharma Stocks Rally on Sanofi, GSK Coronavirus Vaccine Tie-Up

2020-04-09 19:45:10 | Adaptive Biotechnologies Expands Executive Leadership Team to Support Development and Commercialization of Clinical Products, including immunoSEQ Dx

2020-04-09 14:06:00 | These 21 companies are working on coronavirus treatments or vaccines — here’s where things stand

2020-04-07 20:35:00 | Amgen And Adaptive Biotechnologies To Participate In Webinar On COVID-19 Strategic Collaboration

2020-04-03 10:51:02 | Pharma Coronavirus Efforts Continue, Amgen & Incyte Join In

2020-04-03 10:27:00 | With gowns and masks in short supply, researchers test drugs to prevent COVID-19 infections in health care workers

2020-04-02 19:58:13 | Adaptive, Amgen collaborate on development of COVID-19 treatment

2020-04-02 17:50:19 | Covid Report: Amgen Pops As Heavyweight Biotech Enters Coronavirus Ring

2020-04-02 16:23:28 | Biotech Amgen, Adaptive Tech Join Forces on New Coronavirus Drug

2020-04-02 16:04:00 | Coronavirus update: 1 million global cases, 51,485 deaths and U.S. workers file for benefits in record numbers

2020-04-02 09:34:00 | Amgen, Adaptive Biotechnologies ink COVID-19 antibody development collaboration

2020-04-02 09:00:00 | Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19

2020-03-27 14:52:28 | Hedge Funds Interest Was Stagnant In Adaptive Biotechnologies Corporation ADPT Before The Coronavirus

2020-03-24 16:45:42 | Microsoft, Adaptive partner to better diagnose COVID-19 in research with implications for future pandemics

2020-03-23 11:06:03 | Microsoft, Adaptive Biotech Collaborate to Fight COVID-19

2020-03-20 14:00:00 | Chad Cohen shares his IPO playbook after leading two Seattle companies through theirs

2020-03-20 13:02:00 | Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access

2020-02-29 07:12:06 | Here's What Analysts Are Forecasting For Adaptive Biotechnologies Corporation After Its Annual Results

2020-02-27 17:54:38 | Adaptive Biotechnologies poised for big growth in 2020

2020-02-26 16:05:10 | Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2019 Financial Results

2020-02-21 10:20:03 | MEDNAX MD Q4 Earnings and Revenues Surpass Estimates

2020-02-19 16:05:10 | Adaptive Biotechnologies to Present at the 40th Annual Cowen Health Care Conference

2020-02-12 16:05:10 | Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2019 Financial Results on February 26, 2020

2020-02-10 08:44:01 | Why Earnings Season Could Be Great for Adaptive ADPT

2020-02-03 11:27:34 | Andreas Halvorsen Trims Adaptive Biotechnologies Stake

2020-01-31 11:52:08 | Insiders Roundup: Texas Instruments, Homolody Medicines